VVTMF (VVT Med) Accounts Receivable: $0.03 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VVTMF VVT Med Inc VVTMF
2 GF Score
Price $0.16
! 5 Warning Signs
View Full Analysis

What is VVT Med Accounts Receivable?

VVT Med VVTMF 2 Accounts Receivable is $0.03 Mil as of Mar. 2026. GuruFocus rates VVTMF with a GF Score™ of 2/100. The stock has 5 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. VVT Med's accounts receivables for the quarter that ended in Mar. 2026 was $0.03 Mil.

Accounts receivable can be measured by Days Sales Outstanding. VVT Med's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 57.45.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. VVT Med's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was $-0.04.


VVT Med Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

VVT Med's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.034/0.054*91
=57.45

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), VVT Med's accounts receivable are only considered to be worth 75% of book value:

VVT Med's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.066+0.75 * 0.034+0.5 * 0.285-3.181
-0-0)/67.033
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


VVT Med Accounts Receivable Related Terms


VVT Med Accounts Receivable Historical Data

* Premium members only.

The historical data trend for VVT Med's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med Accounts Receivable Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Receivable
0.04 0.03 0.03 0.03

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.02 0.03 0.03
VVTMF
2GF Score
VVT Med Inc VVTMF
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VVT Med Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of $0.03 Mil mean?
VVT Med (VVTMF) has a Accounts Receivable of $0.03 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on VVT Med and its competitors.
Is VVT Med's Accounts Receivable too high?
VVT Med's current Accounts Receivable is $0.03 Mil. Overall, VVT Med has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's Accounts Receivable compare to ABT and SYK?
VVT Med's Accounts Receivable of $0.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Medical Devices & Instruments company?
A good Accounts Receivable depends on the Medical Devices & Instruments industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on VVT Med and its competitors. VVT Med's current Accounts Receivable is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Accounts Receivable of $0.03 Mil. The current Accounts Receivable is $0.03 Mil. VVT Med's overall GF Score™ is 2/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For VVT Med (VVTMF), the current Accounts Receivable is $0.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
2GF Score

Get the complete analysis for VVTMF

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price